Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Clinical Trial Visit of the Future: Leveraging Emerging Technologies to Crack the Patient Recruitment Challenge

Session Chair(s)

Komathi  Stem, MS

Komathi Stem, MS

Chief Operating Officer

Glooko, United States

This workshop will simulate a future clinical trial visit using emerging technologies followed by an expert panel of regulators, industry leaders, and technology developers discussing the opportunities and challenges.

**Due to workshop format, seating will be limited and will be available on a first come, first served basis.

The Boston Convention and Exhibition Center (BCEC) has stringent regulations on maximum room capacities, and they are strictly enforced. Once all seats are occupied, DIA will be required to close the workshop, and no more participants will be admitted. Interested attendees are encouraged to arrive at workshops early in order to ensure seating. Please note, as a workshop with interactivity, this event will not be recorded.

Learning Objective : Discuss novel uses of emerging technologies in clinical trials to increase patient access and improve patient recruitment and retention; Describe best practices and discuss challenges of using novel technologies in clinical trials and the regulatory/legal/patient safety implications.

Speaker(s)

Marc  Foster, MBA

Panelist

Marc Foster, MBA

Transparency Life Sciences, Inc., United States

COO

Lorenzo  Rossaro, MD, FACP

Panelist

Lorenzo Rossaro, MD, FACP

University of California Davis School of Medicine, United States

Chief, Division of Gastroenterology and Hepatology

Craig H Lipset, MPH

Panelist

Craig H Lipset, MPH

Clinical Innovation Partners, United States

Managing Partner

Jonathan Solomon Helfgott, MS

Panelist

Jonathan Solomon Helfgott, MS

Stage 2 Innovations, United States

Executive Director, Global Regulatory/Clinical Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.